France· FR:67596066
BIONOLYTE G10, solution pour perfusion
A medicinal product containing chlorure de potassium + chlorure de sodium + glucose monohydraté, registered in France by FRESENIUS KABI FRANCE.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CHLORURE DE POTASSIUM + CHLORURE DE SODIUM + GLUCOSE MONOHYDRATÉ
- Manufacturer
- FRESENIUS KABI FRANCE
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 4
- cip13340093837796510 flacon(s) polyéthylène de 1000 ml
- cip13340093863606220 poche(s) polypropylène SIS : styrène-isoprène-styrène styrène éthylène butadiène suremballée(s)/surpochée(s) de 500 ml
- cip13340093864250610 poche(s) polypropylène SIS : styrène-isoprène-styrène styrène éthylène butadiène suremballée(s)/surpochée(s) de 1000 ml
- cip13340093837750710 flacon(s) polyéthylène de 500 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Chlorure de potassium + chlorure de sodium + glucose monohydraté in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomIntraven potassium chloride 0.15% (potassium 10mmol/500ml) / glucose 4% / sodium chloride 0.18% infusion 500ml bagsTerumo BCT Ltd
- Canada(20 MMOL/L) POTASSIUM CHLORIDE IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE INJECTION USPBAXTER CORPORATION
- United StatesPotassium Chloride in Dextrose and Sodium ChlorideB. Braun Medical Inc.
- FinlandGlucos.B.Braun 50 Mg/Ml Cum Na40+K20B. Braun Melsungen AG
- CzechiaGNAKBAXTER CZECH spol. s r.o., Praha
- IrelandMaintelyte solution for infusionBaxter Holding B.V.
- NorwayKalium-Natrium-Glucose BraunB. Braun Melsungen AG
Authorised across Europe · EMA
The same active substance is authorised in 10 EEA countries. Names it is sold under:
- Belgium · bionolyte + Glucose, Bionolyte + Glucose
- Denmark · Darrow-Glukose, Kalium-Natrium-Glukose Sad
- Spain · Cloruro De Potasio En Glucosa Y Cloruro De Sodio Kabi, Potasio En Glucosa Y Cloruro De Sodio Grifols
- Finland · Normofundin
- United Kingdom (Northern Ireland) · Potassium Chloride, Sodium Chloride And Glucose Baxter Healthcare
- Ireland · Potassium Chloride, Sodium Chloride And Glucose Baxter
- Luxembourg · Glucose + Nacl + Kcl Baxter
- Norway · Kalium-Natrium-Glucose Braun
- Portugal · Cloreto De Potássio + Glucose + Cloreto De Sódio Grifols
- Sweden · Glukos Med Na40 + K20 Braun
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b4dbc862-6bd2-489a-ad9e-a34e6616c79b GET /v1/drugs/b4dbc862-6bd2-489a-ad9e-a34e6616c79b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "67596066",
"date_amm": "1994-08-18",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "CHLORURE DE POTASSIUM + CHLORURE DE SODIUM + GLUCOSE MONOHYDRATÉ",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution pour perfusion",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about chlorure de potassium + chlorure de sodium + glucose monohydraté.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.